RESEARCH, IN CONTEXT

Understand the compound.
Examine the evidence.

A guide to all 38 visible Premier Aminos listings, with primary sources, evidence limitations and exact external references. Nothing is sold here.

Catalog snapshot: October 26, 2026. Some entries are blends, non-peptide compounds or reagents. Information about an ingredient does not validate a finished product.

38 entries

Other compound

5-Amino-1MQ — capsule listing

This is the capsule listing for 5-Amino-1MQ. The current Premier Aminos listing identifies a different presentation from its research-vial entry. The underlying compound name does not establish equivalence between the formats.

Other compound

5-Amino-1MQ

5-Amino-1MQ is a small-molecule research compound studied as an inhibitor of nicotinamide N-methyltransferase, or NNMT. It is not a peptide.

Peptide

AOD-9604

AOD-9604 is a synthetic peptide related to a region of growth hormone. Its research history includes investigations of lipid metabolism in experimental models.

Laboratory reagent

BAC Water

BAC Water is a laboratory reagent listing, not a peptide. The catalog describes a water formulation containing benzyl alcohol. A reagent has a different purpose from a compound being studied for a biological effect.

Peptide

BPC-157

BPC-157 is a synthetic peptide of 15 amino acids. Research has examined its effects on cellular signaling and responses to injury in experimental systems.

Peptide blend

BPC-157 / TB-500 (Wolverine Blend)

The current catalog describes BPC-157 / TB-500 (Wolverine Blend) as containing BPC-157 + TB-500. This is a seller-listed composition, not an independent assay or verification of the finished product.

Peptide blend

BPC-157/TB500 Nasal

The current catalog describes BPC-157/TB500 Nasal as containing BPC-157 + TB-500. This is a seller-listed composition, not an independent assay or verification of the finished product.

Peptide

CJC-1295 DAC

CJC-1295 is a modified growth hormone-releasing hormone analog. The DAC designation matters: the long-acting compound studied in the cited trial should not be conflated with a product labeled No DAC.

Peptide blend

CJC-1295/IPA

The current catalog describes CJC-1295/IPA as containing CJC-1295 No DAC + ipamorelin. This is a seller-listed composition, not an independent assay or verification of the finished product.

Peptide

DSIP

DSIP stands for delta sleep-inducing peptide; emideltide is another name used in regulatory discussions. A compound’s name can reflect a research hypothesis without establishing a reliable treatment effect.

Other compound

Enclomiphene

Enclomiphene is a non-peptide compound studied in endocrine research. It is one of the compounds discussed in research on selective estrogen receptor modulation.

Peptide

Epithalon

Epithalon, also called Epitalon, is the short synthetic peptide Ala–Glu–Asp–Gly. It is discussed in experimental research on telomeres and cellular aging.

Peptide

GHK-Cu

GHK is a three-amino-acid peptide, glycyl-histidyl-lysine, that binds copper. GHK-Cu refers to the copper-associated complex rather than a single generic skincare ingredient.

Peptide blend

GLOW (GHK-CU/BPC/TB500)

The current catalog describes GLOW (GHK-CU/BPC/TB500) as containing GHK-Cu + BPC-157 + TB-500. This is a seller-listed composition, not an independent assay or verification of the finished product.

Peptide

Glutathione

Glutathione is a tripeptide with the sequence gamma-glutamyl-cysteinyl-glycine. It participates in cellular redox chemistry; that basic role is different from a claim about a particular commercial preparation.

Peptide

IGF-1 LR3

Long R3 IGF-I is an analog studied in the insulin-like growth factor system. It should not be treated as interchangeable with native IGF-I or with a regulated medicine containing a different active substance.

Peptide

Ipamorelin

Ipamorelin is a synthetic pentapeptide investigated as a growth hormone secretagogue. A secretagogue is a substance studied for its ability to stimulate release of another substance.

Peptide blend

KLOW

The current catalog describes KLOW as containing GHK-Cu + KPV + BPC-157 + TB-500. This is a seller-listed composition, not an independent assay or verification of the finished product.

Peptide blend

Klow Capsules

The current catalog describes Klow Capsules as containing GHK-Cu + KPV + BPC-157 + TB-500. This is a seller-listed composition, not an independent assay or verification of the finished product.

Peptide

KPV

KPV is the tripeptide lysine-proline-valine, discussed in melanocortin-related research. Its short sequence should not be mistaken for evidence of simple or predictable effects in people.

Peptide

Melanotan II

Melanotan II is a synthetic cyclic analog of alpha-melanocyte-stimulating hormone. It is examined in melanocortin receptor research and is distinct from other similarly named molecules.

Peptide

MOTS-c

MOTS-c is a mitochondrial-derived peptide investigated in metabolic signaling. Research explores communication between mitochondria, cellular energy pathways and the nucleus.

Other compound

NAD+

NAD+ is nicotinamide adenine dinucleotide, a coenzyme involved in cellular chemistry. It is not a peptide, and NAD+ should not be confused with related precursor molecules such as NMN or NR.

Other compound

NAD+ — spray listing

This is the spray listing for NAD+. The current Premier Aminos listing identifies a different presentation from its research-vial entry. The underlying compound name does not establish equivalence between the formats.

Peptide

Tirzepatide / PA2-T

The site owner identified PA2-T as tirzepatide. Tirzepatide is studied as a dual GIP and GLP-1 receptor agonist. This identity mapping is an owner confirmation, not independent analysis of a batch.

Peptide

Retatrutide / PA3-R

The site owner identified PA3-R as retatrutide. Retatrutide is investigated as an agonist at GIP, GLP-1 and glucagon receptors. The label mapping is owner-confirmed, not a laboratory identity verification.

Topical listing

Premier Bronze Serum

The current catalog describes Premier Bronze Serum as containing Melanotan II + GHK-Cu. This is a seller-listed composition, not an independent assay or verification of the finished product.

Other compound

Premier Burn

The current catalog describes Premier Burn as containing SLU-PP-332 + BAM15. This is a seller-listed composition, not an independent assay or verification of the finished product.

Topical listing

Premier Hair Blend

The current catalog describes Premier Hair Blend as containing Minoxidil + finasteride + RU58841. This is a seller-listed composition, not an independent assay or verification of the finished product.

Peptide blend

Premier Repair

The current catalog describes Premier Repair as containing BPC-157 + TB-500. This is a seller-listed composition, not an independent assay or verification of the finished product.

Other compound

Premier T

The current catalog describes Premier T as containing Enclomiphene citrate + tadalafil. This is a seller-listed composition, not an independent assay or verification of the finished product.

Topical listing

Rejuvenate Serum

The current catalog describes Rejuvenate Serum as containing GHK-Cu + SNAP-8 + KPV. This is a seller-listed composition, not an independent assay or verification of the finished product.

Topical listing

Repair/Revive Serum

The current catalog describes Repair/Revive Serum as containing BPC-157 + TB-500. This is a seller-listed composition, not an independent assay or verification of the finished product.

Peptide blend

Semax/Selank Spray Blend

The current catalog describes Semax/Selank Spray Blend as containing Semax + Selank. This is a seller-listed composition, not an independent assay or verification of the finished product.

Other compound

SLU-PP-332

SLU-PP-332 is a synthetic small molecule investigated as an estrogen-related receptor agonist. Despite often appearing in peptide catalogs, it is not a peptide.

Peptide

SS-31 / elamipretide

SS-31 is a research name associated with elamipretide, a mitochondria-targeting peptide. Discussion of the molecule must be separated from the regulatory status of a particular manufactured medicine.

Peptide

Tesamorelin

Tesamorelin is a growth hormone-releasing factor analog. The active substance appears in specific prescription medicines; a research vial does not share their approved status merely because it has the same compound name.

Peptide

Thymosin alpha-1

Thymosin alpha-1 is a peptide investigated in immune-related research. Immune activity should be described in the context of a specific condition and outcome rather than as a general “boost.”